Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 435160, 25 pages
http://dx.doi.org/10.1155/2015/435160
Review Article

Exhaled Breath Condensate: Technical and Diagnostic Aspects

1Smoking and Lung Cancer Research Centre, Hellenic Cancer Society, 8 Doryleou Street, 11521 Athens, Greece
2Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece

Received 20 January 2015; Accepted 21 April 2015

Academic Editor: Bruno Balbi

Copyright © 2015 Efstathia M. Konstantinidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Horvath, J. Hunt, P. J. Barnes et al., “Exhaled breath condensate: methodological recommendations and unresolved questions,” European Respiratory Journal, vol. 26, no. 3, pp. 523–548, 2005. View at Google Scholar
  2. A. S. Jackson, A. Sandrini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates, “Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 3, pp. 222–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Montuschi, D. Paris, D. Melck et al., “NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis,” Thorax, vol. 67, no. 3, pp. 222–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Aebersold and M. Mann, “Mass spectrometry-based proteomics,” Nature, vol. 422, no. 6928, pp. 198–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Wiktorowicz and M. Jamaluddin, “Proteomics analysis of the asthmatic airway,” in Heterogeneity in Asthma, vol. 795 of Advances in Experimental Medicine and Biology, pp. 221–232, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  6. P. Xiao, J.-R. Chen, F. Zhou et al., “Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer,” Lung Cancer, vol. 83, no. 1, pp. 56–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M.-L. Sinues, R. Zenobi, and M. Kohler, “Analysis of the exhalome: a diagnostic tool of the future,” Chest, vol. 144, no. 3, pp. 746–749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Hakim, S. Billan, U. Tisch et al., “Diagnosis of head and neck cancer from exhaled breath,” British Journal of Cancer, vol. 104, no. 10, pp. 1649–1655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Górski, “Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis,” Chest, vol. 132, no. 2, pp. 589–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Czebe, I. Barta, B. Antus, M. Valyon, I. Horvath, and T. Kullmann, “Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations,” Respiratory Medicine, vol. 102, no. 5, pp. 720–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. R. Carter, C. S. Davis, and E. J. Kovacs, “Exhaled breath condensate collection in the mechanically ventilated patient,” Respiratory Medicine, vol. 106, no. 5, pp. 601–613, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. P. V. Romero, B. Rodrigeuz, S. Martinez, R. Canizares, D. Sepulveda, and F. Manresa, “Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections,” Archivos de Bronconeumologia, vol. 42, no. 3, pp. 113–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Scheideler, H.-G. Manke, U. Schwulera, O. Inacker, and H. Hammerle, “Detection of nonvolatile macromolecules in breath: a possible diagnostic tool?” American Review of Respiratory Disease, vol. 148, no. 3, pp. 778–784, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Vaughan, L. Ngamtrakulpanit, T. N. Pajewski et al., “Exhaled breath condensate pH is a robust and reproducible assay of airway acidity,” European Respiratory Journal, vol. 22, no. 6, pp. 889–894, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Montuschi and P. J. Barnes, “Exhaled leukotrienes and prostaglandins in asthma,” Journal of Allergy and Clinical Immunology, vol. 109, no. 4, pp. 615–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. I. Fairchild and J. F. Stampfer, “Particle concentration in exhaled breath,” American Industrial Hygiene Association Journal, vol. 48, no. 11, pp. 948–949, 1987. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. McCafferty, T. A. Bradshaw, S. Tate, A. P. Greening, and J. A. Innes, “Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations,” Thorax, vol. 59, no. 8, pp. 694–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Debley, A. S. Ohanian, C. F. Spiekerman, M. L. Aitken, and T. S. Hallstrand, “Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate,” Chest, vol. 139, no. 1, pp. 16–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Liu and P. S. Thomas, “Relationship between exhaled breath condensate volume and measurements of lung volumes,” Respiration, vol. 74, no. 2, pp. 142–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Davidsson, K. N. Sjosward, L. Lundman, and B. Schmekel, “Quantitative assessment and repeatability of chlorine in exhaled breath condensate: comparison of two types of condensators,” Respiration, vol. 72, no. 5, pp. 529–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kullmann, I. Barta, B. Antus, M. Valyon, and I. Horvarth, “Environmental temperature and relative humidity influence exhaled breath condensate pH,” European Respiratory Journal, vol. 31, no. 2, pp. 474–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. B. Schleiss, O. Holz, M. Behnke, K. Richter, H. Magnussen, and R. A. Jorres, “The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate,” European Respiratory Journal, vol. 16, no. 6, pp. 1115–1118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. W. Hoyt and A. Honig, Body Fluid Balance: Exercise and Sport, CRC Press, Boca Raton, Fla, USA, 1996.
  24. R. M. Effros, M. B. Dunning III, J. Biller, and R. Shaker, “The promise and perils of exhaled breath condensates,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 287, no. 6, pp. L1073–L1080, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. P. P. R. Rosias, E. Dompeling, H. J. E. Hendriks, J. W. C. M. Heijnens, R. A. M. G. Donckerwolcke, and Q. Jöbsis, “Exhaled breath condensate in children: pearls and pitfalls,” Pediatric Allergy and Immunology, vol. 15, no. 1, pp. 4–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Papineni and F. S. Rosenthal, “The size distribution of droplets in the exhaled breath of healthy human subjects,” Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, vol. 10, no. 2, pp. 105–116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. G. R. Johnson and L. Morawska, “The mechanism of breath aerosol formation,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 22, no. 3, pp. 229–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Hunt, “Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease,” Journal of Allergy and Clinical Immunology, vol. 110, no. 1, pp. 28–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Balbi, P. Pignatti, M. Corradi et al., “Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults,” European Respiratory Journal, vol. 30, no. 4, pp. 769–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. Effros, K. W. Hoagland, M. Boasbous et al., “Dilution of respiratory solutes in exhaled condensates,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 663–669, 2002. View at Google Scholar
  31. P. Rosias, C. Robroeks, J. Hendriks, E. Dompeling, Q. Jöbsis, and I. Rahman, “Exhaled breath condensate: a space odessey, where no one has gone before,” European Respiratory Journal, vol. 24, no. 1, pp. 189–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Cepelak and S. Dodig, “Exhaled breath condensate: a new method for lung disease diagnosis,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 8, pp. 945–952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Montuschi, “Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications,” Therapeutic Advances in Respiratory Disease, vol. 1, no. 1, pp. 5–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. M. Effros, J. Biller, B. Foss et al., “A simple method for estimating respiratory solute dilution in exhaled breath condensates,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 12, pp. 1500–1505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. T. M. Dwyer, “Sampling airway surface liquid: non-volatiles in the exhaled breath condensate,” Lung, vol. 182, no. 4, pp. 241–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Gessner, H. Kuhn, H.-J. Seyfarth et al., “Factors influencing breath condensate volume,” Pneumologie, vol. 55, no. 9, pp. 414–419, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. T. Zakrzewski, N. C. Barnes, J. F. Costello, and P. J. Piper, “Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease,” American Review of Respiratory Disease, vol. 136, no. 3, pp. 779–782, 1987. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Huszar, G. Vass, E. Vizi et al., “Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma,” European Respiratory Journal, vol. 20, no. 6, pp. 1393–1398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Balint, L. E. Donnelly, T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, “Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke,” Thorax, vol. 56, no. 6, pp. 456–461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Montuschi, J. V. Collins, G. Ciabattoni et al., “Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, pp. 1175–1177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Calusic, V. M. Varnai, and J. Macan, “Acute effects of smoking and food consumption on breath condensate pH in healthy adults,” Experimental Lung Research, vol. 37, no. 2, pp. 92–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kullmann, I. Barta, B. Antus, and I. Horvath, “Drinking influences exhaled breath condensate acidity,” Lung, vol. 186, no. 4, pp. 263–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. American Thoracic Society, “Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—1999,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2104–2117, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kullman, I. Barta, Z. Lazar et al., “Exhaled breath condensate pH standardised for CO2 partial pressure,” European Respiratory Journal, vol. 29, no. 3, pp. 496–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. J. C. Ojoo, S. A. Mulrennan, J. A. Kastelik, A. H. Morice, and A. E. Redington, “Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis,” Thorax, vol. 60, no. 1, pp. 22–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. “ATS Workshop Proceedings: exhaled breath condensate nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate,” Proceedings of the American Thoracic Society, vol. 3, pp. 131–145, 2006. View at Publisher · View at Google Scholar
  47. K. Syslová, P. Kačer, B. Vilhanová et al., “Determination of cysteinyl leukotrienes in exhaled breath condensate: method combining immunoseparation with LC-ESI-MS/MS,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 23, pp. 2220–2228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. S. Debley, T. S. Hallstrand, T. Monge, A. Ohanian, G. J. Redding, and J. J. Zimmerman, “Methods to improve measurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls,” Journal of Allergy and Clinical Immunology, vol. 120, no. 5, pp. 1216–1217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. D. Pleil, H. F. Hubbard, J. R. Sobus, K. Sawyer, and M. C. Madden, “Volatile polar metabolites in exhaled breath condensate (EBC): collection and analysis,” Journal of Breath Research, vol. 2, no. 2, Article ID 026001, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Janicka, P. Kubica, A. Kot-Wasik, J. Kot, and J. Namieśnik, “Sensitive determination of isoprostanes in exhaled breath condensate samples with use of liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 893-894, pp. 144–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. Effros, R. Casaburi, J. Su et al., “The effects of volatile salivary acids and bases on exhaled breath condensate pH,” The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 4, pp. 386–392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Gessner, R. Scheibe, M. Wotzel et al., “Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 99, no. 10, pp. 1229–1240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. P. P. Rosias, “Methodological aspects of exhaled breath condensate collection and analysis,” Journal of Breath Research, vol. 6, no. 2, Article ID 027102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. Ž. Vlašić, S. Dodig, I. Čepelak et al., “Iron and ferritin concentrations in exhaled breath condensate of children with asthma,” Journal of Asthma, vol. 46, no. 1, pp. 81–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. R. M. Effros, B. Peterson, R. Casaburi et al., “Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects,” Journal of Applied Physiology, vol. 99, no. 4, pp. 1286–1292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Montuschi, New Perspectives in Monitoring Lung Inflammation. Analysis of Exhaled Breath Condensate, CRC Press, Boca Raton, Fla, USA, 2005.
  57. G. I. Sidorenko, E. I. Zborovskiǐ, and D. I. Levina, “Surface-active properties of the exhaled air condensate (a new method of studying lung function),” Terapevticheskii Arkhiv, vol. 52, no. 3, pp. 65–68, 1980. View at Google Scholar · View at Scopus
  58. M. Janicka, A. Kot-Wasik, J. Kot, and J. Namiesnik, “Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis,” International Journal of Molecular Sciences, vol. 11, no. 11, pp. 4631–4659, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Glowacka, U. Jedynak-Wasowicz, M. Sanak, and G. Lis, “Exhaled eicosanoid profiles in children with atopic asthma and healthy controls,” Pediatric Pulmonology, vol. 48, no. 4, pp. 324–335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. Molina, W. Zhao, S. Sankaran, M. Schivo, N. J. Kenyon, and C. E. Davis, “Design-of-experiment optimization of exhaled breath condensate analysis using a miniature differential mobility spectrometer (DMS),” Analytica Chimica Acta, vol. 628, no. 2, pp. 155–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. C. E. Davis, M. J. Bogan, S. Sankaran et al., “Analysis of volatile and non-volatile biomarkers in human breath using differential mobility spectrometry (DMS),” IEEE Sensors Journal, vol. 10, no. 1, pp. 114–122, 2010. View at Publisher · View at Google Scholar
  62. L. Brunetti, R. Francavilla, R. Tesse et al., “Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis,” Pediatric Allergy and Immunology, vol. 17, no. 6, pp. 422–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Niimi, L. T. Nguyen, O. Usmani, B. Mann, and K. F. Chung, “Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough,” Thorax, vol. 59, no. 7, pp. 608–612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov, “Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?” Chest, vol. 125, no. 6, pp. 2005–2010, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. P. P. R. Rosias, E. Dompeling, M. A. Dentener et al., “Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests,” Pediatric Pulmonology, vol. 38, no. 2, pp. 107–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Antus, I. Barta, T. Kullmann et al., “Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1492–1497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Kostikas, A. I. Papaioannou, K. Tanou et al., “Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control,” Respiratory Medicine, vol. 105, no. 4, pp. 526–532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. J. F. Hunt, K. Fang, R. Malik et al., “Endogenous airway acidification. Implications for asthma pathophysiology,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, pp. 694–699, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, and S. Loukides, “pH in expired breath condensate of patients with inflammatory airway diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 10, pp. 1364–1370, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Brunetti, R. Francavilla, R. Tesse et al., “Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis,” Allergy and Asthma Proceedings, vol. 29, no. 5, pp. 461–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. N. C. Nicolaou, L. A. Lowe, C. S. Murray, A. Woodcock, A. Simpson, and A. Custovic, “Exhaled breath condensate pH and childhood asthma: unselected birth cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 3, pp. 254–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Koczulla, S. Dragonieri, R. Schot et al., “Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients,” Respiratory Research, vol. 10, article 78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. G. MacGregor, S. Ellis, J. Andrews et al., “Breath condensate ammonium is lower in children with chronic asthma,” European Respiratory Journal, vol. 26, no. 2, pp. 271–276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Antczak, D. Nowak, B. Shariati, M. Krol, G. Piasecka, and Z. Kurmanowska, “Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients,” European Respiratory Journal, vol. 10, no. 6, pp. 1235–1241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Teng, P. Sun, J. Zhang et al., “Hydrogen peroxide in exhaled breath condensate in patients with asthma: a promising biomarker?” Chest, vol. 140, no. 1, pp. 108–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Samuelsson, “Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation,” Science, vol. 220, no. 4597, pp. 568–575, 1983. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Ono, H. Mita, M. Taniguchi et al., “Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation,” The Journal of Allergy and Clinical Immunology, vol. 122, no. 4, pp. 768.e1–773.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Carraro, M. Corradi, S. Zanconato et al., “Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction,” The Journal of Allergy and Clinical Immunology, vol. 115, no. 4, pp. 764–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Bikov, R. Gajdocsi, E. Huszar et al., “Exercise increases exhaled breath condensate cysteinyl leukotriene concentration in asthmatic patients,” Journal of Asthma, vol. 47, no. 9, pp. 1057–1062, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. S. T. Holgate, M. Peters-Golden, R. A. Panettieri et al., “Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling,” The Journal of Allergy and Clinical Immunology, vol. 111, no. 1, pp. S18–S36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Antczak, P. Montuschi, S. Kharitonov, P. Gorski, and P. J. Barnes, “Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 3, pp. 301–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. Z. Csoma, S. A. Kharitonov, B. Balint, A. Bush, N. M. Wilson, and P. J. Barnes, “Increased leukotrienes in exhaled breath condensate in childhood asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 10, pp. 1345–1349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Mondino, G. Ciabattoni, P. Koch et al., “Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 4, pp. 761–767, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. P. Cap, J. Chladek, F. Pehal et al., “Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients,” Thorax, vol. 59, no. 6, pp. 465–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Zanconato, S. Carraro, M. Corradi et al., “Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma,” The Journal of Allergy and Clinical Immunology, vol. 113, no. 2, pp. 257–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Montuschi, C. Mondino, P. Koch, P. J. Barnes, and G. Ciabattoni, “Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma,” The Journal of Allergy and Clinical Immunology, vol. 118, no. 2, pp. 347–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Shibata, T. Katsunuma, M. Tomikawa et al., “Increased leukotriene E4 in the exhaled breath condensate of children with mild asthama,” Chest, vol. 130, no. 6, pp. 1718–1722, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. B. Kielbasa, A. Moeller, M. Sanak et al., “Eicosanoids in exhaled breath condensates in the assessment of childhood asthma,” Pediatric Allergy and Immunology, vol. 19, no. 7, pp. 660–669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, “Increased nitrotyrosine in exhaled breath condensate of patients with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1273–1276, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. E. Baraldi, S. Carraro, R. Alinovi et al., “Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations,” Thorax, vol. 58, no. 6, pp. 505–509, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Montuschi, S. A. Kharitonov, G. Ciabattoni, and P. J. Barnes, “Exhaled leukotrienes and prostaglandins in COPD,” Thorax, vol. 58, no. 7, pp. 585–588, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Bodini, C. D'Orazio, D. Peroni et al., “Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections,” Pediatric Pulmonology, vol. 40, no. 6, pp. 494–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. G. E. Carpagnano, G. P. Palladino, D. Lacedonia, A. Koutelou, S. Orlando, and M. P. Foschino-Barbaro, “Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8,” BMC Cancer, vol. 11, article 226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Montuschi, M. Corradi, G. Ciabattoni, J. Nightingale, S. A. Kharitonov, and P. J. Barnes, “Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 216–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. E. Baraldi, L. Ghiro, V. Piovan et al., “Increased exhaled 8-isoprostane in childhood asthma,” Chest, vol. 124, no. 1, pp. 25–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides, “Prostaglandin E2 in the expired breath condensate of patients with asthma,” European Respiratory Journal, vol. 22, no. 5, pp. 743–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. S. K. Shahid, S. A. Kharitonov, N. M. Wilson, A. Bush, and P. J. Barnes, “Increased interleukin-4 and decreased interferon-γ in exhaled breath condensate of children with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1290–1293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. G. E. Carpagnano, O. Resta, M. Gelardi et al., “Exhaled inflammatory markers in aspirin-induced asthma syndrome,” American Journal of Rhinology, vol. 21, no. 5, pp. 542–547, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. G. E. Carpagnano, O. Resta, M. T. Ventura et al., “Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma,” Journal of Internal Medicine, vol. 259, no. 3, pp. 323–331, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. G. E. Carpagnano, M. P. Foschino Barbaro, O. Resta et al., “Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma,” European Journal of Pharmacology, vol. 519, no. 1-2, pp. 175–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. C. M. H. H. T. Robroeks, K. D. G. van de Kant, Q. Jobsis et al., “Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma,” Clinical & Experimental Allergy, vol. 37, no. 9, pp. 1303–1311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. T.-F. Leung, G. W. K. Wong, F. W. S. Ko et al., “Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children,” International Archives of Allergy and Immunology, vol. 137, no. 1, pp. 66–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Profita, S. La Grutta, E. Carpagnano et al., “Noninvasive methods for the detection of upper and lower airway inflammation in atopic children,” The Journal of Allergy and Clinical Immunology, vol. 118, no. 5, pp. 1068–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. G. E. Carpagnano, M. P. F. Barbaro, M. Cagnazzo et al., “Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge,” Chest, vol. 128, no. 5, pp. 3159–3166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Matsunaga, S. Yanagisawa, T. Ichikawa et al., “Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients,” The Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 84–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. K. F. Chung and P. J. Barnes, “Cytokines in asthma,” Thorax, vol. 54, no. 9, pp. 825–857, 1999. View at Publisher · View at Google Scholar · View at Scopus
  107. Z. Zietkowski, R. Skiepko, M. M. Tomasiak, and A. Bodzenta-Lukaszyk, “Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients,” Respiratory Medicine, vol. 102, no. 3, pp. 470–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. Z. Zietkowski, M. M. Tomasiak, R. Skiepko, and A. Bodzenta-Lukaszyk, “RANTES in exhaled breath condensate of stable and unstable asthma patients,” Respiratory Medicine, vol. 102, no. 8, pp. 1198–1202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Bloemen, R. van den Heuvel, E. Govarts et al., “A new approach to study exhaled proteins as potential biomarkers for asthma,” Clinical & Experimental Allergy, vol. 41, no. 3, pp. 346–356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. M. I. Bartoli, F. Novelli, F. Costa et al., “Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases,” Mediators of Inflammation, vol. 2011, Article ID 891752, 7 pages, 2011. View at Publisher · View at Google Scholar
  111. S. Carraro, G. Giordano, G. Piacentini et al., “Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma,” Chest, vol. 144, no. 2, pp. 405–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. Z. Zietkowski, M. M. Tomasiak-Lozowska, R. Skiepko, E. Zietkowska, and A. Bodzenta-Lukaszyk, “Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients,” Respiratory Research, vol. 11, article 110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. Z. Zietkowski, R. Skiepko, M. M. Tomasiak-Lozowska, and A. Bodzenta-Lukaszyk, “Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy,” Advances in Medical Sciences, vol. 56, no. 2, pp. 318–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. Z. Zietkowski, M. M. Tomasiak-Lozowska, R. Skiepko, B. Mroczko, M. Szmitkowski, and A. Bodzenta-Lukaszyk, “High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma,” Respiratory Medicine, vol. 103, no. 3, pp. 379–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. E. M. Klaassen, K. D. van de Kant, Q. Jobsis et al., “Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma,” Pediatric Allergy and Immunology, vol. 25, no. 2, pp. 166–172, 2014. View at Publisher · View at Google Scholar
  116. L. Liu, W. G. Teague, S. Erzurum et al., “Determinants of exhaled breath condensate pH in a large population with asthma,” Chest, vol. 139, no. 2, pp. 328–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Banovic, M. Navratil, Z. Vlasic, R. Z. Topic, and S. Dodig, “Calcium and magnesium in exhaled breath condensate of children with endogenous and exogenous airway acidification,” Journal of Asthma, vol. 48, no. 7, pp. 667–673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. A. M. Fitzpatrick, J. T. Holbrook, C. Y. Wei, M. S. Brown, R. A. Wise, and W. G. Teague, “Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma,” The Journal of Allergy and Clinical Immunology, vol. 2, no. 5, pp. 579.e7–586.e7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. Y. Shimizu, K. Dobashi, J. J. Zhao et al., “Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease,” Respiration, vol. 74, no. 5, pp. 558–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. T. Soyer, O. U. Soyer, E. Birben, U. Kisa, O. Kalayci, and M. Cakmak, “Pepsin levels and oxidative stress markers in exhaled breath condensate of patients with gastroesophageal reflux disease,” Journal of Pediatric Surgery, vol. 48, no. 11, pp. 2247–2250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. A. I. Papaioannou, A. Koutsokera, K. Tanou et al., “The acute effect of smoking in healthy and asthmatic smokers,” European Journal of Clinical Investigation, vol. 40, no. 2, pp. 103–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. A.-R. Koczulla, S. Noeske, C. Herr et al., “Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers,” Respiration, vol. 79, no. 1, pp. 61–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. K. Tanou, A. Koutsokera, T. S. Kiropoulos et al., “Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking,” Clinical & Experimental Allergy, vol. 39, no. 3, pp. 345–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. B. Kane, Z. Borrill, T. Southworth, A. Woodcock, and D. Singh, “Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroids,” Respirology, vol. 14, no. 3, pp. 419–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. L. Bentur, E. Hellou, A. Goldbart et al., “Laboratory and clinical acute effects of active and passive indoor group water-pipe (Narghile) smoking,” Chest, vol. 145, no. 4, pp. 803–809, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. M. L. Nicola, H. B. de Carvalho, C. T. Yoshida et al., “Young ‘healthy’ smokers have functional and inflammatory changes in the nasal and the lower airways,” Chest, vol. 145, no. 5, pp. 998–1005, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. G. E. Carpagnano, S. A. Kharitonov, M. P. Foschino-Barbaro, O. Resta, E. Gramiccioni, and P. J. Barnes, “Increase inflammatory markers in the exhaled breath condensate of cigarette smokers,” European Respiratory Journal, vol. 21, no. 4, pp. 589–593, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. W. Mazur, H. Stark, A. Sovijarvi, M. Myllarniemi, and V. L. Kinnula, “Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers,” Respiration, vol. 78, no. 2, pp. 209–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. J. M. Diez-Pina, M. J. Fernandez-Acenero, M. J. Llorente-Alonso, S. Diaz-Lobato, S. Mayoralas, and A. Florez, “Tumor necrosis factor alpha as a marker of systemic and local inflammation in ‘healthy’ smokers,” International Journal of General Medicine, vol. 2, pp. 9–14, 2009. View at Google Scholar · View at Scopus
  130. D. Celik, S. Doruk, H. I. Koseoglu, S. Sahin, S. Celikel, and U. Erkorkmaz, “Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics,” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 5, pp. 1069–1073, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. K. Kostikas, M. Minas, E. Nikolaou et al., “Secondhand smoke exposure induces acutely airway acidification and oxidative stress,” Respiratory Medicine, vol. 107, no. 2, pp. 172–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. Z. Borrill, C. Starkey, J. Vestbo, and D. Singh, “Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 25, no. 2, pp. 269–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. W. MacNee, S. I. Rennard, J. F. Hunt et al., “Evaluation of exhaled breath condensate pH as a biomarker for COPD,” Respiratory Medicine, vol. 105, no. 7, pp. 1037–1045, 2011. View at Publisher · View at Google Scholar · View at Scopus
  134. A. I. Papaioannou, S. Loukides, M. Minas et al., “Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers,” Respiratory Research, vol. 12, article 67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. P. N. R. Dekhuijzen, K. K. H. Aben, I. Dekker et al., “Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease,” The American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, pp. 813–816, 1996. View at Publisher · View at Google Scholar · View at Scopus
  136. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides, “Oxidative stress in expired breath condensate of patients with COPD,” Chest, vol. 124, no. 4, pp. 1373–1380, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. D. Nowak, M. Kasielski, A. Antczak, T. Pietras, and P. Bialasiewicz, “Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking,” Respiratory Medicine, vol. 93, no. 6, pp. 389–396, 1999. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Corradi, I. Rubinstein, R. Andreoli et al., “Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease,” The American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 10, pp. 1380–1386, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Corradi, P. Pignatti, P. Manini et al., “Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation,” European Respiratory Journal, vol. 24, no. 6, pp. 1011–1017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. B. Antus, G. Harnasi, O. Drozdovszky, and I. Barta, “Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde,” Respirology, vol. 19, no. 1, pp. 74–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  141. K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides, “Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma,” Chest, vol. 127, no. 5, pp. 1553–1559, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. J. L. Izquierdo, C. Almonacid, T. Parra, and J. Perez, “Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease,” Archivos de Bronconeumologia, vol. 42, no. 7, pp. 332–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. Z. L. Borrill, R. C. Starkey, and S. D. Singh, “Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 71–76, 2007. View at Google Scholar · View at Scopus
  144. M. Fumagalli, F. Ferrari, M. Luisetti et al., “Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS,” International Journal of Molecular Sciences, vol. 13, no. 11, pp. 13894–13910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. G. Warwick, P. S. Thomas, and D. H. Yates, “Non-invasive biomarkers in exacerbations of obstructive lung disease,” Respirology, vol. 18, no. 5, pp. 874–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Antczak, M. Ciebiada, T. Pietras, W. J. Piotrowski, Z. Kurmanowska, and P. Gorski, “Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease,” Archives of Medical Science, vol. 8, no. 2, pp. 277–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  147. W. A. Biernacki, S. A. Kharitonov, and P. J. Barnes, “Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD,” Thorax, vol. 58, no. 4, pp. 294–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  148. G. E. Carpagnano, O. Resta, M. P. Foschino-Barbaro et al., “Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys),” European Journal of Pharmacology, vol. 505, no. 1–3, pp. 169–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  149. V. Rihak, P. Zatloukal, J. Chladkova, A. Zimulova, Z. Havlinova, and J. Chladek, “Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis,” Journal of Clinical Laboratory Analysis, vol. 24, no. 5, pp. 317–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. A. R. Koczulla, S. Noeske, C. Herr et al., “Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients,” Respiratory Medicine, vol. 106, no. 1, pp. 120–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  151. S. Kwiatkowska, K. Noweta, M. Zieba, D. Nowak, and P. Bialasiewicz, “Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study,” Respiration, vol. 84, no. 3, pp. 231–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  152. J. L. Corhay, C. Moermans, M. Henket, D. N. Dang, B. Duysinx, and R. Louis, “Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD,” Respiratory Research, vol. 15, no. 1, pp. 115–126, 2014. View at Publisher · View at Google Scholar
  153. N. Kubysheva, S. Soodaeva, L. Postnikova, V. Novikov, A. Maksimova, and A. Chuchalin, “Associations between indicators of nitrosative stress and levels of soluble HLA-I, CD95 molecules in patients with COPD,” Journal of Chronic Obstructive Pulmonary Disease, vol. 11, no. 6, pp. 639–644, 2014. View at Publisher · View at Google Scholar
  154. N. L. Tateosian, M. J. Costa, D. Guerrieri, A. Barro, J. A. Mazzei, and H. E. Chuluyan, “Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients,” Cytokine, vol. 58, no. 3, pp. 361–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. T. Zakharkina, A.-R. Koczulla, O. Mardanova, A. Hattesohl, and R. Bals, “Detection of microorganisms in exhaled breath condensate during acute exacerbations of COPD,” Respirology, vol. 16, no. 6, pp. 932–938, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. E. C. Lases, V. A. M. Duurkens, W. B. M. Gerritsen, and F. J. L. M. Hass, “Oxidative stress after lung resection therapy,” Chest, vol. 117, pp. 99–103, 2000. View at Google Scholar
  157. G. E. Carpagnano, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and F. Carpagnano, “Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer,” International Journal of Biological Markers, vol. 17, no. 2, pp. 141–145, 2002. View at Google Scholar · View at Scopus
  158. G. E. Carpagnano, A. Spanevello, C. Curci et al., “IL-2, TNF-α, and leptin: local versus systemic concentrations in NSCLC patients,” Oncology Research, vol. 16, no. 8, pp. 375–381, 2007. View at Google Scholar · View at Scopus
  159. L. Brussino, B. Culla, C. Bucca et al., “Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer,” Journal of Breath Research, vol. 8, no. 2, Article ID 027110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  160. G. E. Carpagnano, M. P. Foschino-Barbaro, O. Restaa, E. Gramiccioni, and F. Carpagnano, “Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer,” Oncology, vol. 66, no. 3, pp. 180–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  161. E. Dalaveris, T. Kerenidi, A. Katsabeki-Katsafli et al., “VEGF, TNF-α and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer,” Lung Cancer, vol. 64, no. 2, pp. 219–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. T. Kullmann, I. Barta, E. Csiszer, B. Antus, and I. Horvath, “Differential cytokine pattern in the exhaled breath of patients with lung cancer,” Pathology and Oncology Research, vol. 14, no. 4, pp. 481–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. I. Barta, T. Kullmann, E. Csiszer, and B. Antus, “Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma,” International Journal of Biological Markers, vol. 25, no. 1, pp. 52–56, 2010. View at Google Scholar · View at Scopus
  164. W. Jungraithmayr, C. Frings, G. Zissel, A. Prasse, B. Passlick, and E. Stoelben, “Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma,” Respirology, vol. 13, no. 7, pp. 1022–1027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. C. Gessner, B. Rechner, S. Hammerschmidt et al., “Angiogenic markers in breath condensate identify non-small cell lung cancer,” Lung Cancer, vol. 68, no. 2, pp. 177–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  166. G. E. Carpagnano, A. Spanevello, G. P. Palladino et al., “Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?” Lung Cancer, vol. 67, no. 1, pp. 108–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. G. E. Carpagnano, G. P. Palladino, D. Martinelli, D. Lacedonia, S. Orlando, and M. P. Foschino-Barbaro, “Exhaled matrix metalloproteinase-9 in lung cancer,” Rejuvenation Research, vol. 15, no. 4, pp. 359–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  168. Z. Cheng, A. K. Chan, C. R. Lewis, P. S. Thomas, and M. J. Raftery, “Comparative proteomics analysis of exhaled breath condensate in lung cancer patients,” Journal of Cancer Therapy, vol. 2, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar
  169. Y. Zou, L. Wang, C. Zhao et al., “CEA, SCC and NSE levels in exhaled breath condensate—possible markers for early detection of lung cancer,” Journal of Breath Research, vol. 7, no. 4, Article ID 047101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Gessner, H. Kuhn, K. Toepfer, S. Hammerschmidt, J. Schauer, and H. Wirtz, “Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients,” Lung Cancer, vol. 43, no. 2, pp. 215–222, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. G. E. Carpagnano, M. P. Foschino-Barbaro, G. Mule et al., “3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 6, pp. 738–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. G. E. Carpagnano, M. P. Foschino-Barbaro, A. Spanevello et al., “3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 3, pp. 337–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. G. E. Carpagnano, A. Spanevello, F. Carpagnano et al., “Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients,” Lung Cancer, vol. 64, no. 3, pp. 334–340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. G. E. Carpagnano, G. P. Palladino, C. Gramiccioni, M. P. Foschino Barbaro, and D. Martinelli, “Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients,” Lung Cancer, vol. 68, no. 2, pp. 305–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. P. Mozzoni, I. Banda, M. Goldoni et al., “Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer,” Biomarkers, vol. 18, no. 8, pp. 679–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. J. Kordiak, J. Szemraj, K. Hamara, P. Bialasiewicz, and D. Nowak, “Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene,” Respiratory Medicine, vol. 106, no. 9, pp. 1293–1300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  177. W. Han, T. Wang, A. A. Reilly, S. M. Keller, and S. D. Spivack, “Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients,” Respiratory Research, vol. 10, article 86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. G. E. Carpagnano, A. Koutelou, M. I. Natalicchio et al., “HPV in exhaled breath condensate of lung cancer patients,” British Journal of Cancer, vol. 105, no. 8, pp. 1183–1190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  179. G. E. Carpagnano, D. Lacedonia, G. P. Palladino et al., “Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy,” BMC Pulmonary Medicine, vol. 14, no. 1, article 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  180. C. Gessner, S. Hammerschmidt, H. Kuhn et al., “Exhaled breath condensate acidification in acute lung injury,” Respiratory Medicine, vol. 97, no. 11, pp. 1188–1194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  181. B. K. Walsh, D. J. Mackey, T. Pajewski, Y. Yu, B. M. Gaston, and J. F. Hunt, “Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients,” Respiratory Care, vol. 51, no. 10, pp. 1125–1131, 2006. View at Google Scholar · View at Scopus
  182. O. Roca, S. Gomez-Olles, M.-J. Cruz, X. Munoz, M. J. D. Griffiths, and J. R. Masclans, “Mechanical ventilation induces changes in exhaled breath condensate of patients without lung injury,” Respiratory Medicine, vol. 104, no. 6, pp. 822–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. I. Korovesi, E. Papadomichelakis, S. E. Orfanos et al., “Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis,” Anesthesiology, vol. 114, no. 5, pp. 1118–1129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  184. P. Montushi, “Isoprostanes, prostanoids and leukotrienes in exhaled breath condensate,” in New Prespectives in Monitoring Lung Inflammation. Analysis of Exhaled Breath Condensate, P. Montushi, Ed., pp. 53–66, CRC Press, Boca Raton, Fla, USA, 2005. View at Google Scholar
  185. O. Roca, S. Gomez-Olles, M.-J. Cruz, X. Munoz, M. J. D. Griffiths, and J. R. Masclans, “Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis,” Critical Care, vol. 12, no. 3, article R72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. L. J. Nannini, R. Quintana, D. H. Bagilet et al., “Exhaled breath condensate pH in mechanically ventilated patients,” Medicina Intensiva, vol. 37, no. 9, pp. 593–599, 2013. View at Publisher · View at Google Scholar · View at Scopus
  187. C. T. Carpenter, P. V. Price, and B. W. Christman, “Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS,” Chest, vol. 114, no. 6, pp. 1653–1659, 1998. View at Publisher · View at Google Scholar · View at Scopus
  188. S. R. Baldwin, R. H. Simon, C. M. Grum, L. H. Ketai, L. A. Boxer, and L.J. Devall, “Oxidant activity in expired breath of patients with adult respiratory distress syndrome,” The Lancet, vol. 1, no. 8471, pp. 11–14, 1986. View at Google Scholar · View at Scopus
  189. U. Sack, R. Scheibe, M. Wotzel et al., “Multiplex analysis of cytokines in exhaled breath condensate,” Cytometry Part A, vol. 69, no. 3, pp. 169–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  190. E. D. Moloney, S. E. Mumby, R. Gajdocsi et al., “Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 64–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  191. C. Gessner, S. Hammerschmidt, H. Kuhn et al., “Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury,” Chest, vol. 124, no. 3, pp. 1046–1052, 2003. View at Publisher · View at Google Scholar · View at Scopus
  192. C. Gessner, H. Dihazi, S. Brettschneider et al., “Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients,” Respiratory Medicine, vol. 102, no. 2, pp. 299–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  193. G. Horonenko, J. C. Hoyt, R. A. Robbins et al., “Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report,” Chest, vol. 132, no. 1, pp. 58–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  194. S. Chow, P. S. Thomas, M. Malouf, and D. H. Yates, “Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis,” Journal of Breath Research, vol. 6, no. 1, Article ID 016004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  195. S. B. Montesi, S. K. Mathai, L. N. Brenner et al., “Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis,” BMC Pulmonary Medicine, vol. 14, no. 1, article 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  196. S. Tate, G. MacGregor, M. Davis, J. A. Innes, and A. P. Greening, “Airways in cystic fibrosis are acidified: detection by exhaled breath condensate,” Thorax, vol. 57, no. 11, pp. 926–929, 2002. View at Publisher · View at Google Scholar · View at Scopus
  197. B. Antus, I. Barta, E. Csiszer, and K. Kelemen, “Exhaled breath condensate pH in patients with cystic fibrosis,” Inflammation Research, vol. 61, no. 10, pp. 1141–1147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  198. B. Balint, S. A. Kharitonov, T. Hanazawa et al., “Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis,” European Respiratory Journal, vol. 17, no. 6, pp. 1201–1207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  199. S. Celio, H. Troxler, S. S. Durka et al., “Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma,” Nitric Oxide, vol. 15, no. 3, pp. 226–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  200. F. Horak Jr., A. Moeller, F. Singer et al., “Longitudinal monitoring of pediatric cystic fibrosis lung disease using nitrite in exhaled breath condensate,” Pediatric Pulmonology, vol. 42, no. 12, pp. 1198–1206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  201. C. M. H. H. T. Robroeks, P. P. R. Rosias, D. van Vliet et al., “Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children,” Pediatric Allergy and Immunology, vol. 19, no. 7, pp. 652–659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  202. S. Cunningham, J. R. McColm, L. P. Ho, A. P. Greening, and T. G. Marshall, “Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis,” European Respiratory Journal, vol. 15, no. 5, pp. 955–957, 2000. View at Publisher · View at Google Scholar · View at Scopus
  203. G. E. Carpagnano, P. J. Barnes, D. M. Geddes, M. E. Hodson, and S. A. Kharitonov, “Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 8, pp. 1109–1112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  204. A. Bodini, C. D'Orazio, D. G. Peroni et al., “IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children,” International Journal of Immunopathology and Pharmacology, vol. 20, no. 3, pp. 467–472, 2007. View at Google Scholar · View at Scopus
  205. C. M. H. H. T. Robroeks, Q. Jobsis, J. G. M. C. Damoiseaux et al., “Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis,” Annals of Allergy, Asthma and Immunology, vol. 96, no. 2, pp. 349–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  206. G. Warwick, E. Kotlyar, S. Chow, P. S. Thomas, and D. H. Yates, “Exhaled breath condensate in pulmonary arterial hypertension,” Journal of Breath Research, vol. 6, no. 3, Article ID 036006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  207. H. He, Y. Tao, X. Chen et al., “High levels of interleukin-6 and 8-iso-prostaglandin in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension,” Chinese Medical Journal, vol. 127, no. 9, pp. 1608–1612, 2014. View at Publisher · View at Google Scholar · View at Scopus
  208. P. Carratu, C. Scoditti, M. Maniscalco et al., “Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension,” BMC Pulmonary Medicine, vol. 8, article 20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  209. J. K. Mansoor, E. S. Schelegle, C. E. Davis et al., “Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension,” PLoS ONE, vol. 9, no. 4, Article ID e95331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  210. H. Ahmadzai, B. Cameron, J. Chui, A. Lloyd, D. Wakefield, and P. S. Thomas, “Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis,” Journal of Breath Research, vol. 7, no. 4, Article ID 046003, 2013. View at Publisher · View at Google Scholar · View at Scopus
  211. M. A. Biltagi, M. A. Maguid, M. A. Ghafar, and E. Farid, “Correlation of 8-isoprostane, interleukin-6 and cardiac functions with clinical score in childhood obstructive sleep apnoea,” Acta Paediatrica, vol. 97, no. 10, pp. 1397–1405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. A. D. Goldbart, J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal, “Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome,” Chest, vol. 130, no. 1, pp. 143–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  213. G. Malakasioti, E. Alexopoulos, C. Befani et al., “Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA,” Sleep and Breathing, vol. 16, no. 3, pp. 703–708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  214. V. Vlasic, J. Trifunovic, I. Cepelak, P. Nimac, R. Z. Topic, and S. Dodig, “Urates in exhaled breath condensate of children with obstructive sleep apnea,” Biochemia Medica, vol. 21, no. 2, pp. 139–144, 2011. View at Google Scholar · View at Scopus
  215. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, “8-isoprostane in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy,” Chest, vol. 124, no. 4, pp. 1386–1392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  216. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, “Increased 8-isoprostane and interleukin-6 in breath condensate ofobstructive sleep apnea patients,” Chest, vol. 122, no. 4, pp. 1162–1167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  217. S. Antonopoulou, S. Loukides, G. Papatheodorou, C. Roussos, and M. Alchanatis, “Airway inflammation in obstructive sleep apnea: is leptin the missing link?” Respiratory Medicine, vol. 102, no. 10, pp. 1399–1405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  218. M. Westhoff and P. Litterst, “Obstructive sleep apnoea and oxidative stress,” Pneumologie, vol. 66, no. 10, pp. 610–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  219. G. E. Carpagnano, A. Spanevello, R. Sabato et al., “Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8,” Translational Research, vol. 155, no. 1, pp. 35–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  220. A. Nielepkowicz-Gozdzinska, W. Fendler, E. Robak et al., “Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 62, no. 3, pp. 231–238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  221. A. Nielepkowicz-Gozdzinska, W. Fendler, E. Robak et al., “Exhaled cytokines in systemic lupus erythematosus with lung involvement,” Polskie Archiwum Medycyny Wewnetrznej, vol. 123, no. 4, pp. 141–148, 2013. View at Google Scholar · View at Scopus
  222. G. Rolla, M. Bruno, L. Bommarito et al., “Breath analysis in patients with end-stage renal disease: effect of haemodialysis,” European Journal of Clinical Investigation, vol. 38, no. 10, pp. 728–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  223. J. Rysz, M. Kasielski, J. Apanasiewicz et al., “Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis,” Nephrology Dialysis Transplantation, vol. 19, no. 1, pp. 158–163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  224. C. R. E. Esther, R. C. Boucher, M. R. Johnson et al., “Airway drug pharmacokinetics via analysis of exhaled breath condensate,” Pulmonary Pharmacology & Therapeutics, vol. 27, no. 1, pp. 76–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  225. O. Beck, S. Sandqvist, P. Eriksen, J. Franck, and G. Palmskog, “Determination of methadone in exhaled breath condensate by liquid chromatography-tandem mass spectrometry,” Journal of Analytical Toxicology, vol. 35, no. 3, pp. 129–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  226. Hippocrates, The Corpus; The Hippocratic Writings, Kaplan Publishing, New York, NY, USA, 2008.
  227. P. Montuschi, N. Mores, A. Trove, C. Mondino, and P. J. Barnes, “The electronic nose in respiratory medicine,” Respiration, vol. 85, no. 1, pp. 72–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  228. A. Koutsokera, S. Loukides, K. I. Gourgoulianis, and K. Kostikas, “Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values,” Current Medicinal Chemistry, vol. 15, no. 6, pp. 620–630, 2008. View at Publisher · View at Google Scholar · View at Scopus